BioAccord Live Demo

Experience the power of biopharmaceutical attribute analysis made simple: BioAccord LC-MS System Demo (LIVE!): 

Attribute-based analysis of biopharmaceuticals provides powerful data-rich insights into biotherapeutic molecules and the processes that produce them. Ease of obtaining these measurements has traditionally been limited to those with significant LC-MS experience.  

The BioAccord™ System has been developed as a fit-for-purpose system for analysis of biopharmaceutical molecules and process attributes, providing simplicity of access and analysis that produces powerful insights, even for to users of all levels of LC-MS experience. Learn more about it in our live demo.

What You'll Learn:

• Gain an understanding of how attribute-based analysis of biotherapeutics promotes better understanding of molecules and processes.
• Learn how attribute-based analysis can be made simple and accessible, even for to users of all levels of LC-MS experience.

Reserve Your Spot Today!

The live demo will provide attendees with direct experience of how a fit-for-purpose LC-MS system simplifies acquiring biotherapeutic attribute data, how the data is collected and processed, and how these powerful workflows provide insights into biotherapeutic molecules and the processes that produced them.  

Presenter: Heidi Gastall, Ph.D. (Principal Product Manager, Waters Biologics Business)

Heidi Gastall is a Principal Product Manager at Waters Corporation (UK). She works in a multifunctional team to bring LC-MS solutions to customers working in the biopharmaceutical industry. Most recently, she has worked on a series of enhancements to the BioAccord LC-MS System to meet the evolving needs of users analysing proteins, peptides, oligos, nucleic acids and glycans. She has studied proteins using mass spectrometry for over 15 years, at Waters and in previous positions. Her pharmaceutical career began in small molecule and antibody drug discovery at UCB Celltech (UK). There, she observed the direct impact mass spectrometry has on bringing new medicines to patients who need them. During her doctorate at the University of Oxford (UK) she used structural mass spectrometry to characterise small heat shock proteins. She received her undergraduate degree in Chemistry from the University of Cambridge (UK).